• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氧化氮前药JS-K诱导人肝癌HepG2细胞中Ca(2+)介导的凋亡。

The Nitric Oxide Prodrug JS-K Induces Ca(2+)-Mediated Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells.

作者信息

Liu Ling, Wang Dongmei, Wang Jiangang, Wang Shuying

机构信息

Department of Pharmacy, Medical College, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China.

Department of Pathogen Biology, Medical College, Henan University of Science and Technology, Luoyang, 471003, People's Republic of China.

出版信息

J Biochem Mol Toxicol. 2016 Apr;30(4):192-9. doi: 10.1002/jbt.21778. Epub 2015 Nov 30.

DOI:10.1002/jbt.21778
PMID:26616367
Abstract

Hepatocellular carcinoma is one of the most common and deadly forms of human malignancies. JS-K, O(2)-(2, 4-dinitrophenyl) 1-[(4-ethoxycarbonyl) piperazin-1-yl] diazen-1-ium-1, 2-diolate, has the ability to induce apoptosis of tumor cell lines. In the present study, JS-K inhibited the proliferation of HepG2 cells in a time- and concentration-dependent manner and significantly induced apoptosis. JS-K enhanced the ratio of Bax-to-Bcl-2, released of cytochrome c (Cyt c) from mitochondria and the activated caspase-9/3. JS-K caused an increasing cytosolic Ca(2+) and the loss of mitochondrial membrane potential. Carboxy-PTIO (a NO scavenger) and BAPTA-AM (an intracellular Ca(2+) chelator) significantly blocked an increasing cytosolic Ca(2+) in JS-K-induced HepG2 cells apoptosis, especially Carboxy-PTIO. Meanwhile, Carboxy-PTIO and BAPTA-AM treatment both attenuate JS-K-induced apoptosis through upregulation of Bcl-2, downregulation of Bax, reduction of Cyt c release from mitochondria to cytoplasm and inactivation of caspase-9/3. In summary, JS-K induced HepG2 cells apoptosis via Ca(2+)/caspase-3-mediated mitochondrial pathway.

摘要

肝细胞癌是人类最常见且致命的恶性肿瘤形式之一。JS-K,即O(2)-(2, 4-二硝基苯基) 1-[(4-乙氧羰基)哌嗪-1-基]重氮-1, 2-二醇盐,具有诱导肿瘤细胞系凋亡的能力。在本研究中,JS-K以时间和浓度依赖的方式抑制HepG2细胞的增殖,并显著诱导凋亡。JS-K提高了Bax与Bcl-2的比例,促进细胞色素c(Cyt c)从线粒体释放以及激活caspase-9/3。JS-K导致胞质Ca(2+)增加以及线粒体膜电位丧失。羧基-PTIO(一种NO清除剂)和BAPTA-AM(一种细胞内Ca(2+)螯合剂)显著阻断了JS-K诱导的HepG2细胞凋亡过程中胞质Ca(2+)的增加,尤其是羧基-PTIO。同时,羧基-PTIO和BAPTA-AM处理均通过上调Bcl-2、下调Bax、减少Cyt c从线粒体向细胞质的释放以及caspase-9/3的失活来减弱JS-K诱导的凋亡。总之,JS-K通过Ca(2+)/caspase-3介导的线粒体途径诱导HepG2细胞凋亡。

相似文献

1
The Nitric Oxide Prodrug JS-K Induces Ca(2+)-Mediated Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells.一氧化氮前药JS-K诱导人肝癌HepG2细胞中Ca(2+)介导的凋亡。
J Biochem Mol Toxicol. 2016 Apr;30(4):192-9. doi: 10.1002/jbt.21778. Epub 2015 Nov 30.
2
JS-K as a nitric oxide donor induces apoptosis via the ROS/Ca/caspase-mediated mitochondrial pathway in HepG2 cells.JS-K 作为一氧化氮供体通过 ROS/Ca/半胱天冬酶介导的线粒体途径诱导 HepG2 细胞凋亡。
Biomed Pharmacother. 2018 Nov;107:1385-1392. doi: 10.1016/j.biopha.2018.08.142. Epub 2018 Aug 31.
3
Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells.蛋白磷酸酶 2A 的激活机制有助于 JS-K 诱导人肝癌细胞中的 caspase 依赖性细胞凋亡。
J Exp Clin Cancer Res. 2018 Jul 9;37(1):142. doi: 10.1186/s13046-018-0823-2.
4
Protein phosphatase 2A mediates JS-K-induced apoptosis by affecting Bcl-2 family proteins in human hepatocellular carcinoma HepG2 cells.蛋白磷酸酶 2A 通过影响人肝癌 HepG2 细胞中的 Bcl-2 家族蛋白介导 JS-K 诱导的细胞凋亡。
J Cell Biochem. 2018 Aug;119(8):6633-6643. doi: 10.1002/jcb.26845. Epub 2018 Apr 25.
5
JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.JS-K,一种一氧化氮前体药物,可诱导乙肝病毒阳性的肝癌HepG2.2.15细胞发生DNA损伤和凋亡。
Biomed Pharmacother. 2017 Aug;92:989-997. doi: 10.1016/j.biopha.2017.05.141. Epub 2017 Jun 8.
6
JS-K, a nitric oxide prodrug, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells.JS-K,一种一氧化氮前体药物,可诱导HL-60髓系白血病细胞中的细胞色素c释放和半胱天冬酶激活。
Leuk Res. 2006 Oct;30(10):1279-83. doi: 10.1016/j.leukres.2005.12.007. Epub 2006 Jan 24.
7
Effects of JS-K, a novel anti-cancer nitric oxide prodrug, on gene expression in human hepatoma Hep3B cells.新型抗癌一氧化氮前体药物 JS-K 对人肝癌 Hep3B 细胞基因表达的影响。
Biomed Pharmacother. 2017 Apr;88:367-373. doi: 10.1016/j.biopha.2017.01.080. Epub 2017 Jan 22.
8
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53.一氧化氮前药JS-K抑制泛素E1并杀死保留野生型p53的肿瘤细胞。
Oncogene. 2009 Jan 29;28(4):619-24. doi: 10.1038/onc.2008.401. Epub 2008 Nov 3.
9
NG, a novel PABA/NO-based oleanolic acid derivative, induces human hepatoma cell apoptosis via a ROS/MAPK-dependent mitochondrial pathway.NG,一种新型的 PABA/NO 为基础的齐墩果酸衍生物,通过 ROS/MAPK 依赖的线粒体途径诱导人肝癌细胞凋亡。
Eur J Pharmacol. 2012 Sep 15;691(1-3):61-8. doi: 10.1016/j.ejphar.2012.07.031. Epub 2012 Jul 20.
10
A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells.一种活性氧激活机制促成了JS-K诱导的人膀胱癌细胞凋亡。
Sci Rep. 2015 Oct 13;5:15104. doi: 10.1038/srep15104.

引用本文的文献

1
Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics.采用 iTRAQ 蛋白质组学技术鉴定 JS-K 对 HBV 阳性人肝癌 HepG2.2.15 细胞的作用靶点。
Sci Rep. 2021 May 17;11(1):10381. doi: 10.1038/s41598-021-90001-3.
2
Crocin protects against dexamethasone‑induced osteoblast apoptosis by inhibiting the ROS/Ca2+‑mediated mitochondrial pathway.藏红花苷通过抑制 ROS/Ca2+介导的线粒体通路来防止地塞米松诱导的成骨细胞凋亡。
Mol Med Rep. 2019 Jul;20(1):401-408. doi: 10.3892/mmr.2019.10267. Epub 2019 May 22.
3
Glutathione -transferase π: a potential role in antitumor therapy.
谷胱甘肽-S-转移酶π:在抗肿瘤治疗中的潜在作用
Drug Des Devel Ther. 2018 Oct 23;12:3535-3547. doi: 10.2147/DDDT.S169833. eCollection 2018.
4
Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells.蛋白磷酸酶 2A 的激活机制有助于 JS-K 诱导人肝癌细胞中的 caspase 依赖性细胞凋亡。
J Exp Clin Cancer Res. 2018 Jul 9;37(1):142. doi: 10.1186/s13046-018-0823-2.